EVO

New

EVO

EVO by Regenera is the most advanced device for autologous micrografting in the treatment of androgenetic alopecia.

Built upon the clinically validated Rigenera® technology, EVO delivers highly concentrated AMT® Triad — a suspension rich in progenitor cells, smart exosomes, and growth factors — designed to reactivate hair follicle growth in a safe and effective way.

Regenera Activa

Spain

Technology

Technology

The EVO system uses Smart Microblade Technology and a proprietary process of mechanical disaggregation that preserves cell viability (90%+) and enhances the concentration of regenerative elements.

The resulting AMT® Triad effectively combats inflammation, improves microcirculation, and reactivates dormant hair follicles.

Up to 70 billion Smart Exosomes per session
Up to 50% biological components in AMT® Triad
Advanced LCD-controlled intelligent system
Precise, low-stress mechanical disaggregation
No manipulation, no risk of rejection
Fast and easy 30-minute procedure
Clinically proven effectiveness with over 450,000 successful procedures
Supports paracrine signaling, angiogenesis, and hair follicle regeneration

Treatments

treatment of diffuse type androgenic alopecia in men and women (hereditary alopecia)

thinning hair after stress, cicatricial alopecia

anti-aging therapy

difficult healing wounds (including diabetes mellitus)

cartilage regeneration

Before & After AMT® Procedure

BeforeAfter

Result after 3 months following the AMT® procedure

Result after 3 months following the AMT® procedure

Result after 3 months following the AMT® procedure

Result after 3 months following the AMT® procedure

Result after 3 months following the AMT® procedure

Scientific & Clinical Research Library

The published evidence about the AMT® treatment for AGA